Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies (Q24243918)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies (English)

0 references

1 reference

Eduardo Nobile-Orazio

series ordinal

2

object named as

Eduardo Nobile-Orazio

0 references

author name string

Michael PT Lunn

series ordinal

1

0 references

publication date

19 April 2006

0 references

published in

0 references

cites work

A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Treatment of IgM antibody associated polyneuropathies using rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Peripheral neuropathy and monoclonal IgM with antibody activity against peripheral nerve myelin; effect of plasma exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Cladribine in the treatment of IgM paraproteinemic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Polyneuropathies associated with IgM monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Plasma-Cell Dyscrasia and Peripheral Neuropathy with a Monoclonal Antibody to Peripheral-Nerve Myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Successful treatment of IgM paraproteinaemic neuropathy with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Interobserver agreement for the assessment of handicap in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Polyneuropathy with monoclonal gammopathy: Studies of 11 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

AAEE case report #17: Peripheral neuropathy in monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Immune reactive C3d on the surface of myelin sheaths in neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Prevalence of monoclonal protein in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Polyneuropathy in Waldenstr�m's macroglobulinaemia: Reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Response of patients with IgM and IgA-associated peripheral polyneuropathies to "off-line" immunoadsorption treatment using the Prosorba protein A column

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Treatment of patients with neuropathy and anti-MAG IgM M-proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Pulsed high-dose dexamethasone treatment of polyneuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Peripheral neuropathy associated with plasma cell dyscrasia: a clinical and electrophysiological follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Neuropathy accompanying IgM? monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Parameters for monitoring treatment effects in CIDP with anti-MAG/SGPG IgM antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Immunofluorescence study of patients with neuropathy and IgM M proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2

The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002827.PUB2